Nir I. Weijl

1.9k citations

22 papers · 1.4k indexed · h-index 16

Impact in

Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Pathology and Forensic Medicine top 5%
- Chemotherapy-induced organ toxicity mitigation

Papers in

Oncology 12
- Cancer Treatment and Pharmacology 4
- Global Cancer Incidence and Screening 2
- Colorectal Cancer Treatments and Studies 2
Pathology and Forensic Medicine 5
- Genetic factors in colorectal cancer 2

Co-authors: Susanne Osanto F. J. Cleton Eef G.W.M. Lentjes A. H. Zwinderman Howard Berger Aeilko H. Zwinderman Frits R. Rosendaal M A Nooy
Journals: Annals of Oncology (3 papers)European Journal of Cancer (2 papers)The Oncologist (2 papers)Journal of Clinical Oncology (2 papers)Supportive Care in Cancer (2 papers)
Partner nations: Netherlands United States Japan

In The Last Decade

Nir I. Weijl

22 papers receiving 1.3k citations

Peers

Countries citing papers authored by Nir I. Weijl

Since Specialization

Citations

This map shows the geographic impact of Nir I. Weijl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir I. Weijl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir I. Weijl more than expected).

Fields of papers citing papers by Nir I. Weijl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nir I. Weijl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir I. Weijl. The network helps show where Nir I. Weijl may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nir I. Weijl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nir I. Weijl Line = papers co-authored together Nir I. Weijl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer Supportive Care in Cancer ·Pádraig Breathnach, Moniek M. ter Kuile, Nir I. Weijl, Taufik Ahmad Taufik Ahmad, Muhammad Adnan Widodo, Johanneke E.A. Portielje, Judith R. Kroep, Chris Hinnen	2022	9
2	Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study The Oncologist ·Feng Jung Sherida H. Woei-A-Jin, Nir I. Weijl, Mark C. Burgmans, Arantza Fariña Sarasqueta, Tom van Wezel, Martin N.J.M. Wasser, Minneke J. Coenraad, Jacobus Burggraaf, Susanne Osanto	2021	20
3	Using a quality of life (QoL)-monitor: preliminary results of a randomized trial in Dutch patients with early breast cancer Quality of Life Research ·Rieneke T. Lugtenberg, Maarten J. Fischer, Maya Alcántara, Kunihiko Kobayashi, Kenichi Inoue, Ayako Matsuda, Kaoru Kubota, Nir I. Weijl, Kazue Yamaoka, Dewi Kusumasari, J.W.R. Nortier, Hein Putter, Hans Gelderblom, Ad A. Kaptein, Judith R. Kroep	2020	5
4	Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands Clinical Genitourinary Cancer ·Hans M. Westgeest, 周颖怡, Ding Yue, Ronald de Wit, J.L. Coenen, H. Pieter van den Berg, Niven Mehra, Inge M. van Oort, L. Fossion, Mathijs P. Hendriks, Haiko J. Bloemendal, Addy C.M. van de Luijtgaarden, Daan ten Bokkel Huinink, F Ye, ธีรุดม์ ลอตระกูล, Marco B. Polée, Nir I. Weijl, Andries M. Bergman, Carin A. Uyl‐de Groot, Winald R. Gerritsen	2019	5
5	Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan Breast Cancer Research and Treatment ·Maarten J. Fischer, Kenichi Inoue, Ayako Matsuda, Judith R. Kroep, Shigenori E. Nagai, نعمان عز الدين, F. H. Schmidt, Nir I. Weijl, Keicha M. Muriel, Dewi Kusumasari, J.W.R. Nortier, Hein Putter, Kazue Yamaoka, Kaoru Kubota, Kunihiko Kobayashi, Ad A. Kaptein	2017	20
6	Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer Medical Decision Making ·Ellen G. Engelhardt, Arwen H. Pieterse, Paul K. J. Han, M. R. Odekunle, Dennis G. W. Allsop, George V. Gsell, Monique M.E.M. Bos, Nir I. Weijl, Cornelis J.A. Punt, Patricia Quarles van Ufford-Mannesse, H.P. Sleeboom, Johanneke E.A. Portielje, N.M. Chepilko, Feng Jung Sherida H. Woei-A-Jin, Judith R. Kroep, Hanneke C.J.M. de Haes, Ellen M.A. Smets, Anne M. Stiggelbout	2016	38
7	Randomised study of tegafur–uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer — TLC study Journal of Geriatric Oncology ·Judith R. Kroep, Erik van Werkhoven, Marco B. Polée, Cees J. van Groeningen, Aart Beeker, Frans Erdkamp, Nir I. Weijl, Aart van Bochove, Z. Erjavec, Ellen Kapiteijn, Anne M. Stiggelbout, مرتضی شاکر اردکانی, Hans Gelderblom	2015	15
8	Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study The Lancet Oncology ·Nienke A. de Glas, W. van de Water, Ellen G. Engelhardt, Esther Bastiaannet, Anton J.M. de Craen, Judith R. Kroep, Hein Putter, Anne M. Stiggelbout, Nir I. Weijl, Cornelis J.�H. van de Velde, Johanneke E.A. Portielje, Gerrit‐Jan Liefers	2014	52
9	Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer Colorectal Disease ·Lydia G. van der Geest, Johanneke E.A. Portielje, Michel W.J.M. Wouters, Nir I. Weijl, Bea C. Tanis, Rob A.�E.�M. Tollenaar, H. Struikmans, J.W.R. Nortier	2013	47
10	Reversibility of capillary density after discontinuation of bevacizumab treatment Annals of Oncology ·Neeltje Steeghs, Ton J. Rabelink, Jos Op ’t Roodt, Erdogan Batman, Dennis G. W. Allsop, Nir I. Weijl, Eelco J.P. de Koning, Hans Gelderblom	2009	36
11	Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study European Journal of Cancer ·Nir I. Weijl, 大木光一, Eef G.W.M. Lentjes, Kaleigh Bangor, Vera Sofi Khusnia, A. H. Zwinderman, F. J. Cleton, Susanne Osanto	2004	206
12	Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study1 European Journal of Cancer* ·Nir I. Weijl	2004	5
13	Non-protein bound iron release during chemotherapy in cancer patients Clinical Science ·Nir I. Weijl, 大木光一, Ralf M. W. Moison, Eef G.W.M. Lentjes, R. Brand, Howard Berger, Susanne Osanto	2004	17
14	Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·大木光一, Nir I. Weijl, R Luque, A. H. Zwinderman, MANAL ALY ABDEL-KHALEK, WALTER ALBERTO XAVIER, A.D. Tates, Susanne Osanto	2001	56
15	Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases Supportive Care in Cancer ·Judith E. Raber‐Durlacher, Nir I. Weijl, Kim Berg Hansen, Bart de Koning, A. H. Zwinderman, S. Osanto	2000	92
16	Vaccination of Melanoma Patients with an Allogeneic, Genetically Modified Interleukin 2-Producing Melanoma Cell Line Human Gene Therapy ·Susanne Osanto, 沈磊, Nir I. Weijl, Kasumi Kamura, Jakub Kopeć, O. T. Clagett, Norbert Vaessen, J. Han van Krieken, J Hermans, F. J. Cleton, Peter I. Schrier	2000	55
17	Thromboembolic Events During Chemotherapy for Germ Cell Cancer: A Cohort Study and Review of the Literature Journal of Clinical Oncology ·Nir I. Weijl, K. T. Jäkel, Aeilko H. Zwinderman, H.J. Keizer, M A Nooy, Frits R. Rosendaal, F. J. Cleton, Susanne Osanto	2000	163
18	Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients Annals of Oncology ·Nir I. Weijl, Kaleigh Bangor, Vera Sofi Khusnia, Eef G.W.M. Lentjes, Howard Berger, F. J. Cleton, Susanne Osanto	1998	176
19	Free radicals and antioxidants in chemotherapyinduced toxicity Cancer Treatment Reviews ·Nir I. Weijl, F. J. Cleton, Susanne Osanto	1997	269
20	Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment. Journal of Clinical Oncology ·Nir I. Weijl, D van der Harst, Anneke Brand, Y Kooy, Feiyue Wu, J Schröder, Ana Beatriz Silva Da Costa, J. J. van Rood, F. J. Cleton, Susanne Osanto	1993	71

About Nir I. Weijl

Nir I. Weijl is a scholar working on Oncology, Pathology and Forensic Medicine, Hepatology, Otorhinolaryngology and Dermatology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Cancer-related cognitive impairment studies (3 papers), Patient-Provider Communication in Healthcare (3 papers), Global Cancer Incidence and Screening (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Testicular diseases and treatments (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Internal Medicine (78 citations), Pathology and Forensic Medicine (320 citations), Otorhinolaryngology (69 citations), Oncology (418 citations) and Biochemistry (70 citations). Nir I. Weijl has collaborated with scholars based in Netherlands, United States and Japan. Frequent co-authors include Susanne Osanto, F. J. Cleton, Eef G.W.M. Lentjes, A. H. Zwinderman, Howard Berger, Aeilko H. Zwinderman, Frits R. Rosendaal, M A Nooy, H.J. Keizer and Judith E. Raber‐Durlacher. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, The Oncologist, Journal of Clinical Oncology and Supportive Care in Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact